LENSAR (NASDAQ:LNSR) Price Target Raised to $10.00

LENSAR (NASDAQ:LNSR) had its target price increased by BTIG Research from $9.00 to $10.00 in a report published on Thursday morning, MarketBeat.com reports. BTIG Research currently has a buy rating on the stock.

LNSR has been the topic of a number of other reports. Wall Street Zen upgraded LENSAR from a “sell” rating to a “hold” rating in a research report on Saturday, August 15th. Lake Street Capital reissued a “buy” rating and set a $13.00 price objective on shares of LENSAR in a report on Thursday, August 13th. Finally, Weiss Ratings reissued a “sell (d+)” rating on shares of LENSAR in a report on Friday, August 7th. Two equities research analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus target price of $11.50.

LENSAR Trading Up 2.8%

NASDAQ LNSR opened at $8.68 on Thursday. The stock’s 50 day moving average is $6.16 and its two-hundred day moving average is $7.23. The company has a market capitalization of $106.68 million, a price-to-earnings ratio of -26.30 and a beta of 0.89. LENSAR has a 1-year low of $4.95 and a 1-year high of $12.96.

LENSAR (NASDAQ:LNSR) last released its quarterly earnings data on Thursday, August 13th. The company reported $0.10 earnings per share for the quarter, beating the consensus estimate of ($0.16) by $0.26. The company had revenue of $16.50 million for the quarter, compared to analyst estimates of $14.65 million. LENSAR had a negative return on equity of 529.08% and a net margin of 57.57%.

Institutional Inflows and Outflows

A number of institutional investors have recently modified their holdings of LNSR. BNP Paribas Financial Markets boosted its holdings in shares of LENSAR by 129.0% in the 3rd quarter. BNP Paribas Financial Markets now owns 2,008 shares of the company’s stock worth $25,000 after acquiring an additional 1,131 shares in the last quarter. Bank of New York Mellon Corp acquired a new stake in LENSAR during the 2nd quarter valued at $58,000. JPMorgan Chase & Co. increased its holdings in LENSAR by 584.3% during the 2nd quarter. JPMorgan Chase & Co. now owns 4,674 shares of the company’s stock valued at $62,000 after purchasing an additional 3,991 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. acquired a new stake in LENSAR during the 2nd quarter valued at $68,000. Finally, Sanctuary Advisors LLC bought a new position in LENSAR in the 2nd quarter valued at $96,000. Institutional investors own 40.15% of the company’s stock.

About LENSAR

LENSAR, Inc, headquartered in Orlando, Florida, is a medical technology company specializing in advanced laser systems for ophthalmic surgery. Its flagship product, the LENSAR Laser System, combines proprietary three-dimensional imaging with precision-guided femtosecond laser delivery to perform critical steps in cataract procedures, including capsulotomy creation, lens fragmentation and corneal incisions.

Founded in 2005, LENSAR has concentrated its research and development efforts on enhancing surgical accuracy and patient outcomes in cataract treatment.